Sustained suppression of enterohepatic circulation of mycophenolic acid by antimicrobial‐associated diarrhea in a kidney transplant recipient with Crohn's disease: A case report

Abstract Mycophenolic acid (MPA) undergoes enterohepatic circulation. A kidney transplant patient on mycophenolate mofetil was treated with tazobactam/piperacillin for pyelonephritis, and developed antimicrobial‐associated diarrhea. Consequently, the MPA trough level decreased by approximately 90%....

Full description

Bibliographic Details
Published in:	Clinical Case Reports
Main Authors:	Ryota Tanaka, Asami Matsumoto, Ryosuke Tatsuta, Tadasuke Ando, Toshitaka Shin, Hiromitsu Mimata, Hiroki Itoh
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Subjects:	antimicrobial‐associated diarrhea broad‐spectrum antibiotics enterohepatic circulation mycophenolic acid
Online Access:	https://doi.org/10.1002/ccr3.5914

Similar Items

Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipients
by: Ole Martin Drevland, et al.
Published: (2025-07-01)

Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series
by: Mirjam Simoons, et al.
Published: (2023-06-01)

Mycophenolate-induced eosinophilic colitis: A case report
by: Mario Alberto Caviedes-Cleves, et al.
Published: (2023-04-01)

Quantifying Forms and Functions of Enterohepatic Bile Acid Pools in MiceSummary
by: Koichi Sudo, et al.
Published: (2024-01-01)

Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive InhibitionSummary
by: Yoshimi Nakagawa, et al.
Published: (2021-01-01)

The Supplementation of FloraMax-B11 Did Not Affect the Bile Acid Neosynthesis and the Enterohepatic Circulation in Broiler Chickens
by: Kouassi R. Kpodo, et al.
Published: (2022-10-01)

Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery
by: Robin Durník, et al.
Published: (2022-05-01)

Biliary excretion and enterohepatic circulation of thienorphine and its glucuronide conjugate in rats
by: Jingting Deng, et al.
Published: (2012-04-01)

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al.

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
by: Yichen Jia, et al.
Published: (2018-07-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation
by: Melchor Alpízar, et al.
Published: (2024-08-01)

Pharmacological Therapeutic Monitoring of Mycophenolate Mofetil (MMF) in Renal Transplant Recipients.
by: Mohamed Habib BELMAHI, et al.
Published: (2025-03-01)

Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient
by: Ashfaq Hasan, et al.
Published: (2014-01-01)

CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases
by: Prem N. Patel, et al.
Published: (2023-08-01)

Pharmacoeconomic analysis of using drugs containing mycophenolic acid in kidney transplant recipients in the context of domestic pharmaceutical market
by: V. N. Lesovoy, et al.
Published: (2015-08-01)

Mycophenolic acid trough level assessment in patients with lupus nephritis; does it make a difference?
by: Ahmed E. Abdulgalil, et al.
Published: (2025-03-01)

Disposition of Oral Nalbuphine and Its Metabolites in Healthy Subjects and Subjects with Hepatic Impairment: Preliminary Modeling Results Using a Continuous Intestinal Absorption Model with Enterohepatic Recirculation
by: Swati Nagar, et al.
Published: (2024-08-01)

Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key
by: Blanca Norero, et al.
Published: (2017-01-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Gut microbiota derived DCA enhances FOLFOX efficacy via Ugt1a6b mediated enterohepatic circulation in colon cancer
by: Qian Fang, et al.
Published: (2025-03-01)

Effective treatment of steroid‐resistant immune checkpoint inhibitor pneumonitis with mycophenolate mofetil
by: Nao Shioiri, et al.
Published: (2024-04-01)

Comparative genomics analysis to differentiate metabolic and virulence gene potential in gastric versus enterohepatic Helicobacter species
by: Anthony Mannion, et al.
Published: (2018-11-01)

Pharmacokinetics and Enterohepatic Circulation of 2-(Quinoline-8-carboxamido)benzoic Acid (2-QBA) in Mice
by: Ji-Hyeon Jeon, et al.
Published: (2024-07-01)

Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice
by: Yuan Guo, et al.
Published: (2025-12-01)

Pharmacokinetics of mycophenolic acid and its effect on CD4+ and CD8+ T cells after oral administration of mycophenolate mofetil to healthy cats
by: Jennifer E. Slovak, et al.
Published: (2019-09-01)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
by: Hyeyoung Kim, et al.
Published: (2014-09-01)

Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using <i>Ex Vivo</i> T Cell Function Assays
by: Aliede E. in ’t Veld, et al.
Published: (2023-05-01)

Mycophenolate mofetil: an update on its mechanism of action and effect on lymphoid tissue
by: Anna Krawczyk, et al.
Published: (2025-01-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
by: Tomoko Mizaki, et al.
Published: (2023-01-01)

Gut Microbiota-Mediated Pharmacokinetic Drug–Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans
by: Nahathai Dukaew, et al.
Published: (2023-06-01)

Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil
by: Mustafa Çakan, et al.
Published: (2019-10-01)

Mycophenolate suppresses inflammation by inhibiting prostaglandin synthases: a study of molecular and experimental drug repurposing
by: Fahad Al-Hizab, et al.
Published: (2021-04-01)

Mycophenolate Mofetil in the Management of Oral Mucocutaneous Diseases: Current Evidence and Future Perspectives
by: Khalid Aljohani, et al.
Published: (2025-05-01)

Evaluation of neutropenia secondary to mycophenolate mofetil associated with valganciclovir in liver transplant patients
by: Alejandro Ferrer-Machín, et al.
Published: (2021-03-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Review: Gastric and enterohepatic helicobacters other than Helicobacter pylori – The evolving importance of Non-Helicobacter pylori Helicobacter species for public and animal health
by: E. Taillieu, et al.
Published: (2023-10-01)

Selection of <i>Pneumocystis jirovecii</i> Inosine 5′-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid
by: Claire V. Hoffmann, et al.
Published: (2021-10-01)

Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation
by: O Manuel, et al.
Published: (2007-12-01)